Inter Pharma (IP) Stock Overview
Manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
IP Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Inter Pharma Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿4.58 |
| 52 Week High | ฿4.70 |
| 52 Week Low | ฿2.02 |
| Beta | 0.57 |
| 1 Month Change | 15.66% |
| 3 Month Change | 7.51% |
| 1 Year Change | 44.03% |
| 3 Year Change | -47.59% |
| 5 Year Change | -20.46% |
| Change since IPO | 15.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| IP | TH Personal Products | TH Market | |
|---|---|---|---|
| 7D | -0.4% | 3.5% | 0.8% |
| 1Y | 44.0% | -22.6% | -7.9% |
Return vs Industry: IP exceeded the TH Personal Products industry which returned -22.6% over the past year.
Return vs Market: IP exceeded the TH Market which returned -7.9% over the past year.
Price Volatility
| IP volatility | |
|---|---|
| IP Average Weekly Movement | 5.1% |
| Personal Products Industry Average Movement | 4.4% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in TH Market | 8.3% |
| 10% least volatile stocks in TH Market | 1.8% |
Stable Share Price: IP has not had significant price volatility in the past 3 months compared to the TH market.
Volatility Over Time: IP's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Trinnawat Thanitnithiphan | www.interpharma.co.th |
Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equipment and medicines, etc. It also provides pet healthcare and livestock products, such as medical supplies, nutrition therapy, vaccine, supplementary food, probiotic and prebiotic products, animal health food products, animal food, general formula animal food, nutraceuticals and medicine companion products, ear and teeth cleaners, pee pads, shampoos, and medical equipment related to pet and livestock care product, etc. In addition, the company provides care and treatment for patients with general and specialized diseases, such as cardiovascular disease, bone and joint disease, neuropathy, medical diseases, surgical diseases, kidney disease, obstetrics and gynecology, ear, eye, nose, throat diseases, blood diseases, pediatric clinics, etc. It serves retail customers through distributors.
Inter Pharma Public Company Limited Fundamentals Summary
| IP fundamental statistics | |
|---|---|
| Market cap | ฿2.81b |
| Earnings (TTM) | ฿111.34m |
| Revenue (TTM) | ฿2.17b |
Is IP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IP income statement (TTM) | |
|---|---|
| Revenue | ฿2.17b |
| Cost of Revenue | ฿1.28b |
| Gross Profit | ฿892.70m |
| Other Expenses | ฿781.35m |
| Earnings | ฿111.34m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.18 |
| Gross Margin | 41.07% |
| Net Profit Margin | 5.12% |
| Debt/Equity Ratio | 14.2% |
How did IP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/24 12:57 |
| End of Day Share Price | 2025/12/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Inter Pharma Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.